Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 1
2005 3
2006 1
2007 4
2008 2
2009 2
2010 2
2011 9
2012 8
2013 7
2014 13
2015 16
2016 21
2017 13
2018 19
2019 9
2020 13
2021 11
2022 3
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

158 results

Results by year

Filters applied: . Clear all
Page 1
Concomitant antihypertensive medication and outcome of patients with metastatic castration-resistant prostate cancer receiving enzalutamide or abiraterone acetate.
Fiala O, Hošek P, Korunková H, Hora M, Kolář J, Šorejs O, Topolčan O, Filipovský J, Liška V, Santoni M, Buti S, Fínek J. Fiala O, et al. Among authors: topolcan o. Cancer Med. 2024 Jan 2;13(1):e6853. doi: 10.1002/cam4.6853. Online ahead of print. Cancer Med. 2024. PMID: 38164124 Free PMC article.
3D Visualization, Skeletonization and Branching Analysis of Blood Vessels in Angiogenesis.
Ramakrishnan V, Schönmehl R, Artinger A, Winter L, Böck H, Schreml S, Gürtler F, Daza J, Schmitt VH, Mamilos A, Arbelaez P, Teufel A, Niedermair T, Topolcan O, Karlíková M, Sossalla S, Wiedenroth CB, Rupp M, Brochhausen C. Ramakrishnan V, et al. Among authors: topolcan o. Int J Mol Sci. 2023 Apr 23;24(9):7714. doi: 10.3390/ijms24097714. Int J Mol Sci. 2023. PMID: 37175421 Free PMC article.
Enzalutamide or Abiraterone Acetate With Prednisone in the Treatment of Metastatic Castration-resistant Prostate Cancer in Real-life Clinical Practice: A Long-term Single Institution Experience.
Fiala O, Hosek P, Korunkova H, Hora M, Kolar J, Windrichova J, Sorejs O, Topolcan O, Travnicek I, Sedlackova H, Finek J. Fiala O, et al. Among authors: topolcan o. Anticancer Res. 2023 Jan;43(1):463-471. doi: 10.21873/anticanres.16183. Anticancer Res. 2023. PMID: 36585174
158 results